ECDC/EMCDDA report: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs. Part 1

Part 1: Needle and syringe programmes and other interventions for preventing hepatitis C, HIV and injecting risk behaviour
This is the first of two technical reports that present the evidence behind the Guidance on the prevention and control of infectious diseases among people who inject drugs.
The evidence presented here focuses on the effectiveness (and in some cases the cost-effectiveness) of the following interventions: the provision of needles and syringes; the provision of other (non-needle and syringe) drug preparation equipment; the provision of foil to stimulate route transition; the provision of information, education and counselling; knowledge of hepatitis C status; disease treatment; modes of service delivery including supervised injecting facilities; and access to, retention in, and combination of interventions.
Additional evidence on the effectiveness of drug treatment is covered in a companion technical report ‘Evidence for the effectiveness of interventions to prevent infections among people who inject drugs, Part 2: Drug treatment for preventing hepatitis C, HIV and injecting risk behaviour’.